TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Change in odour of vaginal discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants who retry statin therapy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of participants who continue to take statin therapy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: No new cerebrovascular adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Mean Average Error (MAE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Initiation of antiosteoporotic treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Screen Time
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Pain Measurement Through VAS (Visual Analogue Score) at Rest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with liver transplantation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Intra-hepatic and peripheral blood immune cell numbers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Hemodynamic activity in primary auditory cortex
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of morbidity and mortality
Endpoint domain: Mortality/survival
Primary endpoint: Change in HAM-D17 total score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Recurrence of Persistent AF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in the burden of AF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Efficacy of VA dual therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Usability of the AURA_ALZ system
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acceptability of the AURA_ALZ system
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Feasibility of the AURA_ALZ system
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: LAL activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Volumetric parameters of the maxillary tuberosity area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional magnetic resonance imaging of brain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Self-reported knee pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported foot pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: External knee adduction moment impulse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants experiencing a dose limiting toxicity (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Effectiveness of XR-B versus XR-NTX
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of pressure ulcers
Endpoint domain: Adverse events/effects
Primary endpoint: Sensitivity of PSMA-PET and MRI Imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of PSMA-PET and MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of reoperations due to infection
Endpoint domain: Adverse events/effects
Primary endpoint: Sit to stand transition time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects maintaining sinus rhythm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Selenium Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lipopolysaccharide Binding Protein (LBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Zonulin (Haptoglobin-2 Precursor)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: high-quality cleaved embryos rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: blastocyst formation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: high-quality blastocyst rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Clinical management impact
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Infant non-HDL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Infant BMI z-score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Surgical bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Checklist of symptom relief
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Experience with vaccination
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of positive regional lymph nodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lymphatic system outcomes
Primary endpoint: True malignant node
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lymphatic system outcomes
Primary endpoint: SNOT-22 score change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hypothalamic-pituitary-ovarian axis hormones
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: T cell frequency pre-treatment and post-treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of participants who undergo planned surgery within 6 weeks after drug administration
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: accuracy of post-polypectomy surveillance interval assignment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: negative predictive value (NPV) for adenoma in rectosigmoid polyps
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Re-Dislocation Rate
Endpoint domain: Adverse events/effects
Primary endpoint: Patient Satisfaction Scores using Pediatric Outcome Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Complications Rate
Endpoint domain: Adverse events/effects
Primary endpoint: Pain scores using numerical rating scale (NRS, 0 to 10)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain scores using numerical rating scale (VAS, 0 to 10)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in number of study drop-outs, attendance, and adherence
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in average fidelity scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients functionally independent (mRS score 0 to 2) at 90 days
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Cmax of total radioactivity in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-t of total radioactivity in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mass balance recovery of total radioactivity (%Ae)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Half-time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tinnitus Burden
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Histological response of peak esophageal eosinophil per HPF count of ≤6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change from baseline in DSQ (Dysphagia Symptom Questionnaire) score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in effective connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Intraclass correlation coefficient (ICC) for Consistency in Spinopelvic Radiographic Measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in the fear of falling
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in the impact of dizziness on daily life
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in Eating Disorder Cognitions
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Success rate of accessory pancreatic ductography
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effect of revascularization strategies on chronic coronary syndrome patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Estimated local tumor progression rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in body composition parameters (% fat mass, % fat-free mass, BMI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in maximal oxygen consumption (VO2 max)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adenoid Size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Clinical responses including 9 symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequencies and grades of treatment-emergent adverse events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of treatment discontinuation due to treatment-emergent adverse events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of consented and enrolled patients completing at least 2 cycles of mosunetuzumab consolidation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Safety profile of INV-102
Endpoint domain: Adverse events/effects
Primary endpoint: Efficacy of INV-102
Endpoint domain: Physiological/clinical
Primary endpoint: Offspring hemoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Offspring ferritin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cognitive Domain of Bayley Scales of Infant Development (BSID)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Modified Lung Ultrasound Score (LUSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Autophagy flux
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Nocturnal Heart Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Sleep Latency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with Cardiac arrest and/or rhythm disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Absolute change in glycated haemoglobin (HbA1c)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Micheli functional scale (MFS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1 Minute Push-up Test (PUT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Kraus-Weber Test for lower back muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Forgotten joint score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Proportion of non-obstructive coronary heart disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Procedural Anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: University of California-Los Angeles Shoulder score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Constant-Murray Shoulder Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: American Shoulder and Elbow Surgeon score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in MOCA score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Izbicki pain score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Angle of trunk rotation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of biliary complications
Endpoint domain: Adverse events/effects
Primary endpoint: Water Access for Activities of Daily Living
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Patient perceived value of the AMAZE™ disease management platform
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Family Impacts Module of the Pediatric Quality of Life Inventory
Endpoint domain: Life impact
Endpoint subdomain: Family impacts
Primary endpoint: Surgical Simulation Questionnaire Part II
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Satisfaction measurement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pulmonary capillary wedge pressure (PCWP) at 20 W workload
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 2 year local control rate
Endpoint domain: Mortality/survival
Primary endpoint: Percent correct intelligible words from trained/untrained scripts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent correct spoken naming of trained/untrained nouns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative excretion rate of total radioactivity in excreta
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pharmacokinetics (PK) (AUC0-inf) for TNP-2198
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pharmacokinetics (PK) (Cmax) for TNP-2198
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in mean REBA scores during colonoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects developing hypothyroidism post-ICM
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Cumulative Incidence of Plasmodium vivax infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in rate of adequate scanning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in percentage of participants accurately characterizing endoscopic lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Platelet aggregation using ADP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: surgical related muscle loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Catheter dislodgement
Endpoint domain: Adverse events/effects
Primary endpoint: time to the first passage of flatus after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Changes in biomarkers of venous wall remodeling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Transvaginal pelvic ultrasound
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Fist Grip
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent of body fat in kg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Lean muscle mass in kg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in 18-HEPE levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time from first medical contact to final invasive diagnostics and revascularization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: F-glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Composite outcome measure - recurrent CeAD, ischemic stroke, hemorrhagic stroke and/or death
Endpoint domain: Mortality/survival
Primary endpoint: Change in MoCA score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Antibody immune response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Innate and adaptive immune responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence of Antibiotic-Associated diarrhea (AAD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Dermatological Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Time to first rescue opioid analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number and duration of readmissions within one month after randomization
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Number and cause of death (all-cause mortality) within one year after randomization
Endpoint domain: Mortality/survival
Primary endpoint: radiographic progression free survival
Endpoint domain: Mortality/survival
Primary endpoint: Patient adherence to study procedures
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC-A)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Changes in right ventricular function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Safety and tolerability of LNK01002
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum tolerated dose (MTD) and/or recommended phase II dose (RP2D) of LNK01002
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Preliminary antitumor activity of LNK01002
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Median Fold Change of Cytokine Levels From Day 0 to Day 90
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change of NYHA classification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of AICD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reported COVID Test in Last 30 Days at 6 Months Post Baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Sorensen Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in daily cannabis use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Analgesic effect (onset time)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amount of pathological uroflow patterns - Qualitative assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Amount of pathological uroflow patterns - Quantitative assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Maximal flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Accepted electronic (e)Referral to Quitline
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Feasibility (adherence) of the intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in the sagittal pharyngeal airway space
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Complete histological response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Immune repertoire sequencing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: DNA methylome sequencing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disease severity assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Real-world Progression-free Survival (rwPFS)
Endpoint domain: Mortality/survival
Primary endpoint: Change from baseline Canadian Occupational Performance Measure
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change from baseline Health and Behavior Inventory
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from baseline Family Assessment Device-General Functioning
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change from baseline Patient-Reported Outcomes Measurement Information System Bank v1.0- Depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline Patient-Reported Outcomes Measurement Information System Bank v1.0- Anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in psychosocial well-being
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percent of patients achieving clear or almost clear on IGA scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gout Prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CIT score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning